Graft-vs-host disease (GVHD)
Showing 1 - 25 of >10,000
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022
A PMS of JakaviĀ® in Steroid-Refractory Graft-versus-Host Disease
Not yet recruiting
- Graft-versus-Host Disease
- ruxolitinib
- (no location specified)
Jan 11, 2023
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular
Withdrawn
- Graft Vs Host Disease
- DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
- Regular dissolvable intracanalicular plug
-
Boston, MassachusettsMass Eye and Ear
Dec 14, 2021
Acute GVHD Trial (MTX, Corticosteroid)
Not yet recruiting
- Acute Graft Versus Host Disease
- (no location specified)
Jun 26, 2023
GVHD Trial in Chicago (Expressive Writing)
Not yet recruiting
- Graft Versus Host Disease
- Expressive Writing
-
Chicago, IllinoisDepartment of Dermatology, Northwestern University Feinberg Scho
Jan 12, 2023
GVHD, Postbiotics, Butyrate Trial in Seoul (sodium butyrate)
Recruiting
- Graft Versus Host Disease
- +2 more
- sodium butyrate
-
Seoul, Korea, Republic ofSoonchunhyang University Seoul Hospital
Apr 11, 2023
Photopheresis in GvHD After Hematopoietic Transplantation:
Enrolling by invitation
- Graft Vs Host Disease
- Extracorporeal Photopheresis
- Extracorporeal Photopheresis
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli (FPG) - IR
Feb 7, 2023
Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)
Recruiting
- Chronic Graft-Versus-Host Disease
- Allogeneic Stem Cell Transplant
- App
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Acute Graft Versus Host Disease
Not yet recruiting
- GVHD,Acute
- blood sample
-
Detroit, MichiganHenry Ford Health System
Jan 30, 2023
Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention
Recruiting
- Graft Vs Host Disease
- +2 more
- Exercise
- Attention control
-
Boston, Massachusetts
- +1 more
Nov 28, 2022
Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto
Completed
- Myelodysplastic/Myeloproliferative Neoplasm
- +2 more
- Decidual stromal cells (DSC)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)
Recruiting
- GVHD,Acute
- GVHD, Chronic
- Physical exercise
-
Salamanca, SpainUniversity of Salamanca
May 27, 2022
GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))
Not yet recruiting
- Graft Versus Host Disease
- Allogeneic mesenchymal stromal cells (MSCs)
- Extracorporeal photopheresis (ECP)
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022
Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)
Recruiting
- Graft Vs Host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients
Recruiting
- Ocular GVHD
-
Indianapolis, IndianaGlick Eye Institute - Indiana University
Sep 2, 2021
Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)
Active, not recruiting
- Graft Vs Host Disease
- GVHD
- Pacritinib
- +2 more
-
Tampa, Florida
- +1 more
Jul 27, 2022
Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)
Approved for marketing
- Graft-versus-host Disease (GVHD)
- (no location specified)
Jan 26, 2023
Dendritic Cells in Acute or Chronic Skin Graft Versus Host
Recruiting
- Acute Graft-versus-host Disease
- +3 more
- Skin punch biopsy
- Peripheral blood draw
-
Saint Louis, MissouriWashington University School of Medicine
May 31, 2022
Ocular Surface Disease in Chronic Graft-Versus-Host Disease
Recruiting
- Dry Eye
- GVHD
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))
Active, not recruiting
- Chronic Graft-versus-host-disease
- Itacitinib
- Extracorporeal Photopheresis (ECP)
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Jan 30, 2023